Li Watsek
Stock Analyst at Cantor Fitzgerald
(0.42)
# 4,389
Out of 4,707 analysts
121
Total ratings
42.2%
Success rate
-5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Li Watsek
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVB Nuvation Bio | Initiated Coverage: Buy | $12 | $6.61 | +81.54% | 1 | Aug 21, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $300 | $270.09 | +11.07% | 26 | Aug 14, 2026 | |
| ZLAB Zai Lab | Maintained: Buy | $37 | $25.41 | +45.61% | 9 | Aug 6, 2026 | |
| REPL Replimune Group | Upgraded: Buy | n/a | $14.77 | - | 6 | Jul 31, 2026 | |
| ANL Adlai Nortye Group | Maintained: Buy | n/a | $15.51 | - | 2 | Jul 16, 2026 | |
| IMRX Immuneering | Initiated Coverage: Buy | $17 | $4.78 | +255.65% | 1 | Jul 8, 2026 | |
| FTH Faeth Therapeutics | Maintained: Buy | n/a | $39.20 | - | 2 | Jun 3, 2026 | |
| CRIS Curis | Rated: Hold | n/a | $1.27 | - | 4 | Mar 27, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $26.73 | - | 2 | Mar 4, 2026 | |
| AVBP ArriVent BioPharma | Initiated Coverage: Buy | n/a | $30.28 | - | 1 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.21 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.06 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.3763 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.08 | - | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $38.84 | n/a | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.52 | n/a | 8 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.93 | n/a | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.10 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.88 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.01 | n/a | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.18 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.1077 | n/a | 4 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.50 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.0131 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $38 | $3.23 | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $6 | $13.96 | n/a | 3 | Jun 28, 2022 |
Nuvation Bio
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.61
Upside: +81.54%
Ascendis Pharma
Aug 14, 2026
Reiterated: Buy
Price Target: $300
Current: $270.09
Upside: +11.07%
Zai Lab
Aug 6, 2026
Maintained: Buy
Price Target: $37
Current: $25.41
Upside: +45.61%
Replimune Group
Jul 31, 2026
Upgraded: Buy
Price Target: n/a
Current: $14.77
Upside: -
Adlai Nortye Group
Jul 16, 2026
Maintained: Buy
Price Target: n/a
Current: $15.51
Upside: -
Immuneering
Jul 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $4.78
Upside: +255.65%
Faeth Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $39.20
Upside: -
Curis
Mar 27, 2026
Rated: Hold
Price Target: n/a
Current: $1.27
Upside: -
Tyra Biosciences
Mar 4, 2026
Maintained: Buy
Price Target: n/a
Current: $26.73
Upside: -
ArriVent BioPharma
Dec 22, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $30.28
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $2.21
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $29.06
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.3763
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $9.08
Upside: -
Sep 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $38.84
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $12.52
Upside: n/a
Jun 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $13.93
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.10
Upside: n/a
May 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $3.88
Upside: n/a
Jan 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.01
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.18
Upside: n/a
Aug 30, 2023
Maintained: Buy
Price Target: $11
Current: $0.1077
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $5
Current: $2.50
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $8 → $5
Current: $0.0131
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $71 → $38
Current: $3.23
Upside: n/a
Jun 28, 2022
Maintained: Buy
Price Target: $16 → $6
Current: $13.96
Upside: n/a